A5039419056- Cardiac Arrhythmias and Treatments
- Cardiac pacing and defibrillation studies
- Atrial Fibrillation Management and Outcomes
- Cardiac electrophysiology and arrhythmias
- Cardiomyopathy and Myosin Studies
- Cardiac Structural Anomalies and Repair
- Vascular anomalies and interventions
- Renal and Vascular Pathologies
- Cardiovascular Function and Risk Factors
- Neuroscience and Neural Engineering
- Pediatric Urology and Nephrology Studies
- Cardiovascular Syncope and Autonomic Disorders
Azienda Ospedaliera S.Giuseppe Moscati
2021-2024
Azienda Ospedaliera G.Rummo
2020-2022
Azienda di Rilievo Nazionale ed Alta Specializzazione
2021
Hospital Montecelo
2015
Abstract Introduction Pulmonary vein (PV) isolation is the cornerstone of catheter ablation in patients with atrial fibrillation (AF). Surround flow and contact force (CF) measurement capabilities might enhance procedure efficacy safety. We report on safety midterm a novel for PV AF. Methods results Two hundred thirty‐three consecutive (57 ± 11 years, 76% males, 51% structural heart disease), referred paroxysmal (157) or persistent (76) AF, underwent by surround CF capability four centers....
Abstract Background The Brugada syndrome (BrS) is an inherited disorder associated with the risk of ventricular fibrillation and sudden cardiac death (SCD). current main therapy implantable cardioverter-defibrillator (ICD). However, stratification management patients remain challenging. Here, we present a case BrS representative pitfalls that clinicians may encounter in routine clinical practice. Case summary A 39-year-old man recurring syncope was implanted subcutaneous ICD (S-ICD) (EMBLEM...
Abstract Introduction Left ventricular (LV) lead optimal positioning is one of the most important determinants cardiac resynchronization therapy (CRT) success. LV quadripolar active fixation (QAF) leads have been designed to ensure stable pacing in target area and reduce likelihood phrenic nerve stimulation (PNS). The aim this analysis compare performances, safety, clinical outcomes QAF with those passive (QPL) bipolar (BAF) a real‐world cohort CRT patients. Methods Results This...
Background Cardiac resynchronization therapy (CRT) is an established treatment in patients with heart failure and prolonged QRS duration. A biventricular device implanted to achieve faster activation more synchronous contraction of the ventricles. Despite convincing effect CRT, 30–40% do not respond. We decided investigate role multipoint pacing (MPP) a selected group right ventricle (RV)-to-left (LV) intervals less than 80 ms that respond traditional CRT. Methods will enrol 248 this...
Abstract Methods and results A 58 years-old man was admitted to our intensive care unit for syncope due inconstant capture of epicardial ventricular lead. His cardiovascular history began 20 years before when he underwent single chamber pacemaker implantation with insertion a passive fixation lead symptomatic complete atrio block (AVB). Electrical parameters were good at implantation. However, during follow-up gradual progressive increase pacing threshold occurred, no changes in impedance...
Purpose of the study: The proper localization an oblique orientated accessory pathways (AP) and ability to detect clear AP potentials on ablation catheter are crucial for successful ablation. We report a case recurring conduction that was finally eliminated using novel equipped with high-resolution mini-electrodes. Method used: A 35-year-old male patient presented RF Wolff–Parkinson–White syndrome. manifest left lateral suspected based delta wave polarity ECG. Electrophysiological study...
Abstract A 53-years old man presented to our institution with a diagnosis of decompensated heart failure NYHA Class IV. He had history ischaemic disease severe biventricular dysfunction, diabetes, hypertension, dyslipidaemia, advanced chronic kidney disease, previous explanation dual-chamber implantable electronic device (ICD) due endocarditis and subsequent implantation subcutaneous ICD in primary prevention. Home therapy included uptitrated angiotensin-converting enzyme inhibitor,...